Dubridge; Robert B.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dubridge; Robert B..The latest application filed is for "constrained conditionally activated binding proteins".
Company Profile
11.34.31
- Dubridge; Robert B. - Belmont CA
Patent Activity
| Patent | Date |
|---|---|
| Single domain serum albumin binding protein Grant 11,453,716 - Dubridge , et al. September 27, 2 | 2022-09-27 |
| Constrained Conditionally Activated Binding Proteins App 20220273794 - MAY; Chad ; et al. | 2022-09-01 |
| Constrained Conditionally Activated Binding Proteins App 20220273795 - MAY; Chad ; et al. | 2022-09-01 |
| Constrained conditionally activated binding proteins Grant 11,406,710 - May , et al. August 9, 2 | 2022-08-09 |
| CONDITIONALLY ACTIVATED BINDING PROTEINS CONTAINING Fc REGIONS AND MOIETIES TARGETING TUMOR ANTIGENS App 20220144949 - DUBRIDGE; Robert B. ; et al. | 2022-05-12 |
| Coexpression And Purification Method Of Conditionally Activated Binding Proteins App 20210309756 - DuBridge; Robert B. ; et al. | 2021-10-07 |
| Compositions and methods for TCR reprogramming using fusion proteins Grant 11,085,021 - Baeuerle , et al. August 10, 2 | 2021-08-10 |
| PSMA Targeting Trispecific Proteins and Methods of Use App 20210095047 - BAEUERLE; Patrick ; et al. | 2021-04-01 |
| PSMA targeting trispecific proteins and methods of use Grant 10,844,134 - Baeuerle , et al. November 24, 2 | 2020-11-24 |
| Constrained Conditionally Activated Binding Proteins App 20200347132 - MAY; Chad ; et al. | 2020-11-05 |
| Mesothelin Binding Proteins App 20200289646 - WESCHE; Holger ; et al. | 2020-09-17 |
| Msln Targeting Trispecific Proteins And Methods Of Use App 20200270362 - WESCHE; Holger ; et al. | 2020-08-27 |
| MSLN targeting trispecific proteins and methods of use Grant 10,730,954 - Wesche , et al. | 2020-08-04 |
| Single Chain Variable Fragment Cd3 Binding Proteins App 20200231672 - DUBRIDGE; Robert B. ; et al. | 2020-07-23 |
| Mesothelin binding proteins Grant 10,543,271 - Wesche , et al. Ja | 2020-01-28 |
| Single chain variable fragment CD3 binding proteins Grant 10,544,221 - Dubridge , et al. Ja | 2020-01-28 |
| Constrained Conditionally Activated Binding Proteins App 20190076524 - MAY; Chad ; et al. | 2019-03-14 |
| Single Domain Serum Albumin Binding Protein App 20190031749 - DUBRIDGE; Robert B. ; et al. | 2019-01-31 |
| Mesothelin Binding Proteins App 20180326060 - WESCHE; Holger ; et al. | 2018-11-15 |
| Msln Targeting Trispecific Proteins And Methods Of Use App 20180327508 - WESCHE; Holger ; et al. | 2018-11-15 |
| Single domain serum albumin binding protein Grant 10,100,106 - Dubridge , et al. October 16, 2 | 2018-10-16 |
| Single chain variable fragment CD3 binding proteins Grant 10,066,016 - Dubridge , et al. September 4, 2 | 2018-09-04 |
| PSMA Targeting Trispecific Proteins and Methods of Use App 20180162949 - BAEUERLE; Patrick ; et al. | 2018-06-14 |
| Inducible Binding Proteins And Methods Of Use App 20180134789 - BAEUERLE; Patrick ; et al. | 2018-05-17 |
| Single domain serum albumin binding protein Grant 9,920,115 - Dubridge , et al. March 20, 2 | 2018-03-20 |
| Single Domain Serum Albumin Binding Protein App 20170369563 - DUBRIDGE; Robert B. ; et al. | 2017-12-28 |
| Single Chain Variable Fragment Cd3 Binding Proteins App 20170369575 - DUBRIDGE; Robert B. ; et al. | 2017-12-28 |
| Single Domain Serum Albumin Binding Protein App 20170334979 - DUBRIDGE; Robert B. ; et al. | 2017-11-23 |
| Single Chain Variable Fragment Cd3 Binding Proteins App 20170334997 - DUBRIDGE; Robert B. ; et al. | 2017-11-23 |
| CTLA4 proteins and their uses Grant 9,587,007 - Akamatsu , et al. March 7, 2 | 2017-03-07 |
| Anti-TNF-alpha antibodies and their uses Grant 9,315,573 - Harding , et al. April 19, 2 | 2016-04-19 |
| Anti-VEGF antibodies and their uses Grant 9,079,953 - Harding , et al. July 14, 2 | 2015-07-14 |
| Ctla4 Proteins And Their Uses App 20150051158 - AKAMATSU; Yoshiko ; et al. | 2015-02-19 |
| Anti-HER2 antibodies and their uses Grant 8,937,159 - Harding , et al. January 20, 2 | 2015-01-20 |
| CTLA4 proteins and their uses Grant 8,883,971 - Akamatsu , et al. November 11, 2 | 2014-11-11 |
| Anti-tnf-alpha Antibodies And Their Uses App 20140212424 - Harding; Fiona A. ; et al. | 2014-07-31 |
| Anti-TNF-.alpha. antibodies and their uses Grant 8,722,860 - Harding , et al. May 13, 2 | 2014-05-13 |
| Anti-EGFR antibodies and their uses Grant 8,658,175 - Dubridge , et al. February 25, 2 | 2014-02-25 |
| CTLA4 proteins and their uses Grant 8,642,557 - Akamatsu , et al. February 4, 2 | 2014-02-04 |
| Ctla4 Proteins And Their Uses App 20130330338 - AKAMATSU; Yoshiko ; et al. | 2013-12-12 |
| ANTI-TNF-a ANTIBODIES AND THEIR USES App 20120135005 - Harding; Fiona A. ; et al. | 2012-05-31 |
| Massively parallel signature sequencing by ligation of encoded adaptors Grant RE43,097 - Albrecht , et al. January 10, 2 | 2012-01-10 |
| Anti-her2 Antibodies And Their Uses App 20110177095 - Harding; Fiona A. ; et al. | 2011-07-21 |
| Anti-egfr Antibodies And Their Uses App 20110117110 - AKAMATSU; Yoshiko ; et al. | 2011-05-19 |
| Anti-vegf Antibodies And Their Uses App 20100322931 - Harding; Fiona A. ; et al. | 2010-12-23 |
| Anti-tnf-alpha Antibodies And Their Uses App 20100266613 - Harding; Fiona A. ; et al. | 2010-10-21 |
| Therapeutic Use Of Anti-cs1 Antibodies App 20090246852 - Williams; Marna ; et al. | 2009-10-01 |
| Efficient generation of expression cell lines through the use of scorable homeostatic reporter genes App 20060286671 - DuBridge; Robert B. | 2006-12-21 |
| Therapeutic use of anti-CS1 antibodies App 20060024296 - Williams; Marna ; et al. | 2006-02-02 |
| Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes App 20040115814 - DuBridge, Robert B. | 2004-06-17 |
| Homologous recombination for universal donor cells and chimeric mammalian hosts Grant 6,514,752 - Kucherlapati , et al. February 4, 2 | 2003-02-04 |
| Solid phase selection of differentially expressed genes Grant 6,511,802 - Albrecht , et al. January 28, 2 | 2003-01-28 |
| Solid phase selection of differentially expressed genes Grant 6,265,163 - Albrecht , et al. July 24, 2 | 2001-07-24 |
| Adaptor-based sequence analysis Grant 6,175,002 - DuBridge , et al. January 16, 2 | 2001-01-16 |
| Homologous recombination for allogeneic donor cells Grant 6,139,835 - Kucherlapati , et al. October 31, 2 | 2000-10-31 |
| Massively parallel signature sequencing by ligation of encoded adaptors Grant 6,013,445 - Albrecht , et al. January 11, 2 | 2000-01-11 |
| Adaptor-based sequence analysis Grant 5,888,737 - DuBridge , et al. March 30, 1 | 1999-03-30 |
| DNA sequencing by stepwise ligation and cleavage Grant 5,714,330 - Brenner , et al. February 3, 1 | 1998-02-03 |
| Combined cellular and immunosuppressive therapies Grant 5,670,148 - Sherwin , et al. September 23, 1 | 1997-09-23 |
| Homologous recombination for universal donor cells and chimeric mammalian hosts Grant 5,574,205 - Kucherlapati , et al. November 12, 1 | 1996-11-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 